-
New Zealand: 14th and Final Subject Enrolled
-
New Zealand Ibogaine Study Receives Generous Donation
-
New Zealand Ibogaine Study Enrolls Sixth and Seventh Subjects
-
New Zealand Ibogaine Study Enrolls Fifth Subject
-
Ibogaine Researcher Thomas Kingsley Brown, Ph.D., Presents at Global Ibogaine Therapist Alliance
-
Ibogaine Treatment for Addiction: Last Subject Completes Follow-Up in Mexico Study
-
3rd International Ibogaine Providers Conference
-
Ibogaine for Addiction: First Two Subjects Enrolled in New Zealand Study
-
Ibogaine Trial Worth the Risk
-
Ibogaine: Seventh Subject Completes Follow-Up in Observational Study in Mexico
-
New Zealand Observational Ibogaine Study for Addiction Approved by Ethics Committee
-
Ibogaine: Fourth Subject Completes Follow-Up in Observational Study in Mexico
-
Amendment to Ibogaine Addiction Study Approved by Review Committee
-
New Zealand Observational Study of Ibogaine Treatment for Addiction Receives Conditional Approval
-
Clinical Team Prepares Protocol for New Study of Ibogaine Treatment for Addiction in New Zealand
-
Observational Study of Ibogaine Treatment for Addiction Enrolls Final Subject
-
New Study of Ibogaine Treatment for Addiction Planned for New Zealand
-
Long-Term Ibogaine Treatment for Addiction Outcome Study Progresses
-
MAPS Offers $25,000 for Clinical Trial of Ibogaine
-
Fifth Subject Enrolled in Ibogaine Study/Protocol Amended